Reproductive & Hormonal
Menotropins (hMG)
Human menopausal gonadotropin; Menopur; hMG
1 min read · Updated July 27, 2026 · 2 references
Curated by PeptideInfo Wikilast reviewed how we verify
An approved biologic fertility medicine standardized by FSH and LH activity; it is a mixture, not one chemically defined peptide.
Evidence: Regulator-approved drug with human trial evidence.
Approved in: FDA (United States; assisted reproductive technology)
- An approved biologic fertility medicine standardized by FSH and LH activity; it is a mixture, not one chemically defined peptide.
- Its gonadotropin activity drives ovarian follicular development during assisted reproductive technology.
- Ovarian hyperstimulation syndrome, thromboembolism, multiple gestation and pregnancy complications are major risks. Ultrasound and estradiol monitoring are integral, not optional extras.
An approved biologic fertility medicine standardized by FSH and LH activity; it is a mixture, not one chemically defined peptide.
Overview
An approved biologic fertility medicine standardized by FSH and LH activity; it is a mixture, not one chemically defined peptide.
Primary regulatory source
This is an educational reference, not individual medical advice. Use requires a prescriber and indication-specific monitoring.
Identity and mechanism
Its gonadotropin activity drives ovarian follicular development during assisted reproductive technology.
Menotropins is a biologic mixture standardized by FSH and LH activity; assigning one molecular formula or PubChem structure would be misleading.
Regulatory label facts
FDA (United States; assisted reproductive technology).
The dose below reproduces a regulator-approved label; it is not a treatment recommendation. Menopur label: an individualized IVF protocol starting at 225 IU subcutaneously daily from cycle day 2 or 3, adjusted after 5 days; maximum 450 IU/day and 20 treatment days.
Safety boundary
Ovarian hyperstimulation syndrome, thromboembolism, multiple gestation and pregnancy complications are major risks. Ultrasound and estradiol monitoring are integral, not optional extras.
This is an educational reference, not individual medical advice. Use requires a prescriber and indication-specific monitoring.
References
Frequently asked questions
- What is Menotropins (hMG)?
- An approved biologic fertility medicine standardized by FSH and LH activity; it is a mixture, not one chemically defined peptide.
- Is Menotropins (hMG) approved as a medicine, and where?
- It is an approved prescription medicine, but where it is approved matters: FDA (United States; assisted reproductive technology). It should only be used under medical supervision.
- What is Menotropins (hMG) studied for?
- Menotropins (hMG) is most often discussed in the context of approved peptide medicines — verification pilot. Being studied for an area does not mean it is proven or approved for it.
- Does Menotropins (hMG) have human clinical trials?
- Yes. Menotropins (hMG) has been studied in human clinical trials and is an approved medicine in at least some regions.
Educational disclaimer. This article summarizes published research for informational purposes and is not medical advice. Menotropins (hMG) is an approved medicine within the stated approval scope (FDA (United States; assisted reproductive technology)) and must only be used under medical supervision; research-grade or unprescribed material is not a lawful substitute. Consult a qualified healthcare professional before making health decisions.